Cardinal Health said on November 13, 2024 it entered into an Underwriting Agreement with BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the underwriters, for the sale of notes.

1. 01

   Cardinal Health said on November 13, 2024 it entered into an Underwriting Agreement with BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the underwriters, for the sale of notes.

2. 02

   The company said it is selling $500,000,000 aggregate principal amount of 4.700% Notes due 2026 and $750,000,000 aggregate principal amount of 5.000% Notes due 2029.

3. 03

   It said it is also selling $1,000,000,000 aggregate principal amount of 5.350% Notes due 2034 and $650,000,000 aggregate principal amount of 5.750% Notes due 2054.

4. 04

   The company said the notes were offered under its effective registration statement on Form S-3 (Registration Statement No. 333-268237) previously filed with the Securities and Exchange Commission. A copy of the Underwriting Agreement is attached as Exhibit 1.1.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.